Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by HarvardUon Jan 05, 2011 3:47am
342 Views
Post# 17926018

RE: RE: RE: chart attempt #2

RE: RE: RE: chart attempt #2

About Us

Launched in 2008, Sirona Biochem specializes in carbohydrate-based chemistry.  Using a proprietary chemistry technique, we aim to improve the properties of carbohydrate-based drugs to make them more commercially viable. 

Sirona Biochem has developed a chemistry technique that we believe can enhance carbohydrate-based molecules.  Carbohydrate-based molecules offer immense potential for the development of therapeutics, cosmeceuticals and biological ingredients.  But these types of molecules are finicky and usually unstable as they tend to break down, making them challenging to produce.  Sirona Biochem uses a proprietary fluorination process to enhance the properties of these molecules. 

We believe our chemistry method can be applied to drugs in development to improve their properties, discontinued drugs that may have been shelved for stability reasons, or for the development of new products for cosmetics and biological manufacturing.  Using our proprietary chemistry process, we feel we can maximize the commercial value of carbohydrate-based molecules.

Sirona Biochem is applying its chemistry expertise towards the development of diabetes and obesity therapeutics, anti-aging cosmetic ingredients and biological ingredients

Bullboard Posts